Abstract
We developed a particle agglutination test (KPA) with poly(gamma-methyl L-glutamate) as the solid particle for measurement of pertussis toxin (PT) antibody. In this study, KPA was assessed as a means of serodiagnosing pertussis, and the results were compared with those of indirect enzyme-linked immunosorbent assay (indirect ELISA) and the microagglutination test. First, four serum samples were collected from each of 21 healthy children: before and 4 weeks after receiving three primary doses of acellular pertussis vaccines and before and 4 weeks after receiving a booster dose. In all 21 vaccinees, a significant rise in PT antibody titers was observed by KPA after each vaccination, and among all 84 serum samples collected, an excellent correlation was demonstrated between the values obtained by indirect ELISA and those obtained by KPA (r = 0.92). Second, paired serum samples were collected at intervals of approximately 2 weeks from 51 patients with culture-confirmed pertussis. A significant increase in titer (fourfold or more) was observed in 39 (76%) patients by KPA, 34 (67%) patients by indirect ELISA, and 23 (45%) patients by the microagglutination test. In acute- and convalescent-phase sera collected from 20 nonpertussis patients, there were no changes in titers by KPA. The KPA procedure was as simple as that of the microagglutination test, and the reaction time was only 2 h (or overnight). In this study, KPA was demonstrated to be a simple, speedy, sensitive, and specific serodiagnostic method for pertussis.
Full Text
The Full Text of this article is available as a PDF (123.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Granström G., Wretlind B., Salenstedt C. R., Granström M. Evaluation of serologic assays for diagnosis of whooping cough. J Clin Microbiol. 1988 Sep;26(9):1818–1823. doi: 10.1128/jcm.26.9.1818-1823.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Granström M., Granström G., Gillenius P., Askelöf P. Neutralizing antibodies to pertussis toxin in whooping cough. J Infect Dis. 1985 Apr;151(4):646–649. doi: 10.1093/infdis/151.4.646. [DOI] [PubMed] [Google Scholar]
- Hallander H. O., Storsaeter J., Möllby R. Evaluation of serology and nasopharyngeal cultures for diagnosis of pertussis in a vaccine efficacy trial. J Infect Dis. 1991 May;163(5):1046–1054. doi: 10.1093/infdis/163.5.1046. [DOI] [PubMed] [Google Scholar]
- Meade B. D., Deforest A., Edwards K. M., Romani T. A., Lynn F., O'Brien C. H., Swartz C. B., Reed G. F., Deloria M. A. Description and evaluation of serologic assays used in a multicenter trial of acellular pertussis vaccines. Pediatrics. 1995 Sep;96(3 Pt 2):570–575. [PubMed] [Google Scholar]
- Thomas M. G., Ashworth L. A., Miller E., Lambert H. P. Serum IgG, IgA, and IgM responses to pertussis toxin, filamentous hemagglutinin, and agglutinogens 2 and 3 after infection with Bordetella pertussis and immunization with whole-cell pertussis vaccine. J Infect Dis. 1989 Nov;160(5):838–845. doi: 10.1093/infdis/160.5.838. [DOI] [PubMed] [Google Scholar]
- Watanabe M., Nakase Y., Aoyama T., Ozawa H., Murase Y., Iwata T. Serotype and drug susceptibility of Bordetella pertussis isolated in Japan from 1975 to 1984. Microbiol Immunol. 1986;30(5):491–494. doi: 10.1111/j.1348-0421.1986.tb02975.x. [DOI] [PubMed] [Google Scholar]